※Title and date of other disclosure related to this one
2022-04-15 Resolutions for Convocation of General Meeting of Shareholders
2022-04-15 Closure of Register of Shareholders or Designation of Record Date
2022-05-27 Outcomes of Extraordinary General Meeting of Shareholders
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bioneer Corporation published this content on 27 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 May 2022 08:48:14 UTC.
BIONEER CORPORATION is a Korea-based company engaged in the biotechnology business. The Company mainly focuses on the development of deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits and other services, such as DNA and ribonucleic acid (RNA) amplification products, Oligo synthesis and reagents, gene synthesis services, gene expressions, protein expressions and purifications, genomics services, human diagnostics kits, veterinary diagnostics kits and others. It also provides DNA devices, including DNA extraction, amplification and quantitative analysis devices and other DNA diagnostic devices, and supplies for tests and others. In addition, it provides equipment and supplies used for biotechnology research. The Company operates its business within domestic market and in overseas markets, including America, China, Japan, India, Africa and others.
BIONEER CORPORATION 
